心肌损伤生物标志物在儿童急性感染性腹泻病伴心肌损伤中的研究进展
Progress of Myocardial Injury Biomarkers in Acute Infectious Diarrheal Disease with My-ocardial Injury in Children
摘要: 近年来，儿童急性感染性腹泻病在临床上发生率仍偏高，且病情发展较为迅速，未及时处理可能会引起机体出现一系列的病理及生理改变，严重时还会引起多器官功能受损，其并发症中较常出现的是心肌损伤，而心肌损伤如不及时诊断治疗将导致心衰等严重后果。因此早期识别及评估心肌损伤严重程度至关重要。目前临床上除使用较多的心肌损伤标志物外，随着医学的发展，近年来出现了多种新型心肌损伤标志物，在诊断儿童急性感染性腹泻伴心肌损伤中具有重要的价值。本文将心肌损伤生物标志物在儿童急性感染性腹泻病伴心肌损伤中的研究进展作如下综述。
Abstract: In recent years, the incidence of acute infectious diarrheal disease in children is still high in clinical practice, and the disease develops relatively rapidly, which may cause a series of pathological and physiological changes in the body without timely management, and in severe cases, it may also cause multi-organ functional impairment. Therefore, early identification and assessment of the se-verity of myocardial injury is crucial. In addition to the more commonly used myocardial injury markers, with the development of medicine, several new myocardial injury markers have emerged in recent years, which are of great value in the diagnosis of acute infectious diarrhea with myocar-dial injury in children. In this paper, the research progress of myocardial injury biomarkers in chil-dren with acute infectious diarrhea with myocardial injury is reviewed as follows.
文章引用：任苏杰, 吴秀萍. 心肌损伤生物标志物在儿童急性感染性腹泻病伴心肌损伤中的研究进展[J]. 临床医学进展, 2023, 13(7): 12118-12125. https://doi.org/10.12677/ACM.2023.1371699

参考文献

[1] 倪鑫, 等. 儿童急性感染性腹泻病诊疗规范(2020年版) [J]. 中国医药科学, 2020, 10(21): 249-256.
[2] 冯迎军. 儿童腹泻病合并心肌损伤41例临床治疗分析. 临床医学, 2011, 31(4): 95-96.
[3] 叶伟平, 邱海燕, 吴军华. 儿童心肌损伤生物标志物的应用和研究进展[J]. 浙江医学, 2018, 40(17): 1980-1985.
[4] 徐向勇, 李正峰, 申建维. 缺血修饰清蛋白在儿童心肌损伤中的临床价值研究[J]. 国际检验医学杂志, 2013, 34(12): 1529-1530.
[5] 章国忠, 潘继豹, 李晓菊. 肌钙蛋白I测定在轮状病毒肠炎并心肌损害的意义[J]. 小儿急救医学, 2004, 11(6): 400-400.
[6] 尚丽. 腹泻引起小儿病毒性心肌炎1例报告[J]. 中国实用乡村医生杂志, 2010, 17(2): 42.
[7] 王鸿利. 实验诊断学[M]. 第2版. 北京: 人民卫生出版社, 2012: 164-168.
[8] 邓颖敏, 区文玑, 郑曙明. 感染性腹泻患儿心肌酶谱的变化[J]. 广东医学, 1998, 19(12): 938-939.
[9] 张丽, 王士雯, 赵玉生. 心肌肌钙蛋白I在心血管疾病中的应用[J]. 心血管病学进展, 1997, 18(5): 298-301.
[10] 张玉凤, 万涵, 符佳, 王军, 徐鹏飞, 袁娟, 邓慧玲. CK-MB、cTnI及BNP检测对小儿轮状病毒性肠炎心肌损害的临床意义[J]. 中国临床医生杂志, 2018, 46(10): 1233-1235.
[11] 罗远红. 营心汤治疗急性病毒性心肌炎的临床观察[D]: [硕士学位论文]. 广州: 广州中医药大学, 2011.
[12] 徐莹莹, 金晶晶. 轮状病毒肠炎致心肌损伤患儿血清GDF-15、hs-CRP水平及临床意义的研究[J]. 中国妇幼保健, 2019, 34(24): 5676-5679.
[13] 包志丹, 万俊, 凌厉. 不同程度窒息所致心肌损伤新生儿血浆BNP的临床分析[J]. 临床肺科杂志, 2013, 18(4): 675-676.
[14] 董艳, 纪冰, 张元德. 急性肠炎患儿血清脂肪酸结合蛋白的检测及临床意义[J]. 滨州医学院学报, 2005, 28(1): 47-48.
[15] 郭玮, 潘柏申. 心肌损伤的其他早期生化标志物[J]. 上海医学检验杂志, 2000, 15(1): 11-12, 15.
[16] 袁海生, 杨立顺. 心肌型脂肪酸结合蛋白的新近研究进展[J]. 国际检验医学杂志, 2015, 36(14): 2086-2089.
[17] Choromańska, B., Myśliwiec, P., Dadan, J., Hady, H. and Chabowski, A. (2011) The Clinical Significance of Fatty Acid Binding Proteins. Postpy Higieny i Medycyny Dowiadczalnej (Advances in Hygiene and Experimental Medicine), 65, 759-763. [Google Scholar] [CrossRef] [PubMed]
[18] Luiken, J.J.F.P., Koonen, D.P.Y., Coumans, W.A., Pelsers, M.M.A.L., Binas, B., Bonen, A. and Glatz, J.F.C. (2003) Long-Chain Fatty Acid Uptake by Skeletal Muscle Is Impaired in Homozygous, but Not Heterozygous, Heart-Type- FABP Null Mice. Lipids, 38, 491-496. [Google Scholar] [CrossRef] [PubMed]
[19] 孙鸿. 心脏型脂肪酸结合蛋白在早期心肌损伤中的诊断价值[J]. 山西医药杂志, 2014, 43(22): 2666-2668.
[20] 王红艳, 赵晓云, 杨法中, 张萍, 李小慧. 心脏型脂肪酸结合蛋白在急性缺血心肌中的表达[J]. 实用医学杂志, 2009, 25(2): 188-190.
[21] 王万相, 马达, 王小平, 等. 脂肪酸结合蛋Ij: 急性心肌梗塞诊断中的应用[J]. 中华检验医学杂志, 2001, 24(4): 220.
[22] 潘朝阳. 心型脂肪酸结合蛋白在体外循环心内直视术后心肌损伤的早期检测价值[J]. 江西医药, 2018, 53(10): 1077-1079.
[23] 易辉建. 缺血修饰白蛋白与血清心肌肌钙蛋白Ⅰ对小儿病毒性心肌炎的诊断价值[J]. 中国实用医刊, 2015, 42(7): 105-106.
[24] 阎蓉. 几种常见心肌损伤生化标志物检测的应用价值[J]. 中国基层医药, 2014, 21(3): 418-419.
[25] Zoair, A., Mawlana, W., Abo-Elenin, A. and Korrat, M. (2015) Serum Level of Heart-Type Fatty Acid Binding Protein (H-FABP) before and after Treatment of Congestive Heart Failure in Children. Pediatric Cardiology, 36, 1722-1727. [Google Scholar] [CrossRef] [PubMed]
[26] Kastritis, E., Papassotiriou, I., Merlini, G., et al. (2018) Growth Differentiation Factor-15 Is a New Biomarker for Survival and Renal Outcomes in Light Chain Amyloidosis. Blood, 131, 1568-1575. [Google Scholar] [CrossRef] [PubMed]
[27] Kempf, T., Horn-Wichmann, R., Brabant, G., et al. (2007) Circulating Concentrations of Growth-Differentiation Factor 15 in Apparently Healthy Elderly Individuals and Patients with Chronic Heart Failure as Assessed by a New Immunoradiometric Sandwich Assay. Clinical Chemistry, 53, 284-291. [Google Scholar] [CrossRef] [PubMed]
[28] Kempf, T., Eden, M., Strelau, J., et al. (2006) The Transform-ing Growth Factor-β Superfamily Member Growth-Dif- ferentiation Factor-15 Protects the Heart from Ische-mia/Reperfusion Injury. Circulation Research, 98, 351-360. [Google Scholar] [CrossRef] 
[29] 张玉涛. 心力衰竭患者超敏肌钙蛋白T、超敏C反应蛋白、生长分化因子-15及氨基末端脑钠肽的临床价值[D]: [硕士学位论文]. 济南: 山东大学, 2018.
[30] Paralkar, V.M., Vail, A.L., Grasser, W.A., Brown, T.A., Xu, H., Vukicevic, S., Ke, H.Z., Qi, H., Owen, T.A. and Thompson, D.D. (1998) Cloning and Characterization of a Novel Member of the Transforming Growth Fac-tor-Beta/Bone Morphogenetic Protein Family. Journal of Biological Chemistry, 273, 13760-13767. [Google Scholar] [CrossRef] [PubMed]
[31] Ikeda, Y., Kumagai, H., Motozawa, Y. and Suzuki, J.-I. (2016) Growth Differentiation Factor 15 (GDF15) as a Reliable Biomarker for Cardiovascular Risk Assessment. International Heart Journal, 57, 1-2. [Google Scholar] [CrossRef] [PubMed]
[32] Schopfer, D.W., Ku, I.A., Regan, M. and Whooley, M.A. (2014) Growth Differentiation Factor 15 and Cardiovascular Events in Patients with Stable Ischemic Heart Disease (The Heart and Soul Study). American Heart Journal, 167, 186-192. [Google Scholar] [CrossRef] [PubMed]
[33] 刘雅东, 富路, 刘佳, 于秀峰, 杨静. 生长分化因子-15在急性冠脉综合征中的临床研究[J]. 现代生物医学进展, 2015, 15(2): 391-393.
[34] 郭迎春, 徐美玉. 生长分化因子-15在心肌损伤危重病患儿中的临床价值[J]. 中华实用儿科临床杂志, 2013, 28(6): 432-434.
[35] 于飞, 陈小平, 尚小森. GDF-15基因+157A/T位点多态性与急性非ST段抬高性心肌梗死侧支循环形成的相关性[J]. 中西医结合心脑血管病杂志, 2014, 12(5): 541-543.
[36] Wang, F.F., Chen, B.X., Yu, H.Y., et al. (2016) Correlation between Growth Differentiation Factor-15 and Collagen Metabolism Indicators in Patients with Myocardial Infarction and Heart Failure. Journal of Geriatric Cardiology: JGC, 13, 88-93.
[37] 陈丽红, 朱屹华, 吴明. 血清心脏型脂肪酸结合蛋白联合糖原磷酸化酶脑型检测在小儿脓毒症心肌损伤诊断中的临床价值[J]. 临床和实验医学杂志, 2021, 20(3): 276-279.
[38] Dobric, M., Ostojic, M., Giga, V., et al. (2014) Glycogen Phosphorylase BB in Myocarciial Infarction. Clinica Chimica Acta, 438, 107-111. [Google Scholar] [CrossRef] [PubMed]
[39] 石苗茜, 苏菲菲, 李俊峡, 郑强荪, 封志纯. 小儿脓毒症心肌损伤的临床诊断与治疗现状[J]. 现代生物医学进展, 2017, 17(14): 2789-2792.
[40] 付建平, 张俊岭, 扈晓霞, 等. 血清缺血修饰白蛋白和同型半胱氨酸水平与冠心病患者心肌缺血程度的关系研究[J]. 实用心脑肺血管病杂志, 2019, 27(4): 13-16.
[41] 姜浩. 61例窒息新生儿心肌损害的临床诊断分析[J]. 中国妇幼保健, 2016, 31(3): 529-531.
[42] 焦书丽, 易庆军, 任丹. 病毒性心肌炎患儿血清IMA、h-FABP水平变化及与心肌损害的相关性[J]. 中国现代医学杂志, 2020, 30(20): 91-94.
[43] Bartel, D.P. (2009) MicroRNAs: Target Recognition and Regulatory Functions. Cell, 136, 215-233. [Google Scholar] [CrossRef] [PubMed]
[44] Olivieri, F., Antonicelli, R., Spazzafumo, L., et al. (2014) Admis-sion Levels of Circulating miR-499-5p and Risk of Death in Elderly Patients after Acute Non-ST Elevation Myocardial Infarction. International Journal of Cardiology, 172, e276-e278. [Google Scholar] [CrossRef] [PubMed]
[45] Cao, C., Zhang, Y., Chai, Y., et al. (2019) Attenuation of Sep-sis-Induced Cardiomyopathy by Regulation of MicroRNA-23b Is Mediated through Targeting of MyD88-Mediated NF-κB Activation. Inflammation, 42, 973-986. [Google Scholar] [CrossRef] [PubMed]
[46] 黄春才, 柴艳芬. 新型心肌损伤标志物的急诊应用研究进展[J]. 中国急救医学, 2018, 38(5): 455-461.
[47] 陈发超, 徐银川, 张召才. 新型生化标志物在脓毒症心肌损伤中的诊断价值研究进展[J]. 中国全科医学, 2021, 24(5): 533-538.
[48] Kalbitz, M., Grailer, J.J., Fattahi, F., et al. (2015) Role of Extracellular Histones in the Cardiomyopathy of Sepsis. The FASEB Journal, 29, 2185-2193. [Google Scholar] [CrossRef] [PubMed]

为你推荐